Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
$78,000 |
 |
AmarinAMRN |
$520,000 |
 |
Gilead SciencesGILD |
-$2.35B |
 |
Anavex Life SciencesAVXL |
-$6.3M |
 |
AmgenAMGN |
-$169M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Saxonov Serge | Mar 2, 2026 | Sell | 14,292 | $22.669 | $320,000 |
| Saxonov Serge | Mar 2, 2026 | Sell | 1,860 | $23.1781 | $43,000 |
| Teichmann Sarah A. | Feb 25, 2026 | Sell | 7,579 | $19.41 | $150,000 |
| Saxonov Serge | Feb 23, 2026 | Sell | 9,632 | $18.5764 | $180,000 |
| Taich Adam | Feb 23, 2026 | Sell | 8,968 | $18.5764 | $170,000 |
| Hindson Benjamin J. | Feb 23, 2026 | Sell | 7,826 | $18.5764 | $150,000 |
| Taich Adam | Nov 24, 2025 | Sell | 11,888 | $18.9983 | $230,000 |
| Saxonov Serge | Nov 24, 2025 | Sell | 13,261 | $18.9983 | $250,000 |
| Hindson Benjamin J. | Nov 24, 2025 | Sell | 8,283 | $18.9983 | $160,000 |
| Taich Adam | Aug 22, 2025 | Sell | 22,315 | $13.787 | $310,000 |
| Saxonov Serge | Aug 22, 2025 | Sell | 9,348 | $13.787 | $130,000 |
| Hindson Benjamin J. | Aug 22, 2025 | Sell | 7,486 | $13.787 | $100,000 |
| Saxonov Serge | May 22, 2025 | Sell | 9,343 | $8.2993 | $78,000 |
| Hindson Benjamin J. | May 22, 2025 | Sell | 7,485 | $8.2993 | $62,000 |
| Taich Adam | May 22, 2025 | Sell | 4,044 | $8.2993 | $34,000 |
| Saxonov Serge | Feb 28, 2025 | Sell | 7,942 | $10.6262 | $84,000 |
| Hindson Benjamin J. | Feb 24, 2025 | Sell | 4,573 | $11.0656 | $51,000 |
| Saxonov Serge | Feb 24, 2025 | Sell | 5,092 | $11.0656 | $56,000 |
| MATEO ALAN | Feb 21, 2025 | Buy | 40,000 | $11.1393 | $450,000 |
| Saxonov Serge | Nov 22, 2024 | Sell | 6,693 | $13.6878 | $92,000 |
| Hindson Benjamin J. | Nov 22, 2024 | Sell | 5,807 | $13.6878 | $79,000 |
| Saxonov Serge | Aug 22, 2024 | Sell | 6,749 | $22.5297 | $150,000 |
| Hindson Benjamin J. | Aug 22, 2024 | Sell | 4,351 | $22.5297 | $98,000 |
| McAnear Justin J. | Aug 22, 2024 | Sell | 2,961 | $22.5297 | $67,000 |
| McAnear Justin J. | May 22, 2024 | Sell | 2,936 | $24.3036 | $71,000 |
| Saxonov Serge | May 22, 2024 | Sell | 4,877 | $24.3036 | $120,000 |
| Hindson Benjamin J. | May 22, 2024 | Sell | 4,087 | $24.3036 | $99,000 |
FAQ - Insider Transactions
The most recent insider transaction for 10X Genomics was conducted by Saxonov Serge, who sold 14,292 shares on March 2, 2026 at a price of $22.67 per share.
MATEO ALAN has bought the most TXG stock in the last 2 years, with a total value of $450,000.
Saxonov Serge has sold the most TXG stock in the last 2 years, with a total value of $1.5M.
The total value of insider transactions for 10X Genomics in the last 2 years is negative, amounting to -$2.9M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
Over the last 2 years, insider transactions for 10X Genomics have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
